Searchable abstracts of presentations at key conferences in endocrinology

ea0073aep482 | Pituitary and Neuroendocrinology | ECE2021

Factors that contribute to dopamine agonist resistance of prolactinomas

Berdeli Maria , Trifanescu Raluca , Caragheorgheopol Andra , Anda Dumitraşcu , Poiana Catalina

IntroductionProlactinomas are the most common hormone-secreting pituitary tumours encountered in the clinic. They are usually treated with dopamine agonists (DA): bromocriptine (BRC) and cabergoline (CAB), which are highly effective in the majority of cases. DA resistance is the failure to achieve normal levels of prolactin and, or reduction of the adenoma with at least 50%.Aimto assess the prevalence of the ...

ea0073aep536 | Pituitary and Neuroendocrinology | ECE2021

Pituitary apoplexy- a single-center, retrospective study of clinical outcomes

Ghenoiu Sandra , Gheorghe Diana Maria , Ciubotaru Gheorghe Vasile , Anda Dumitraşcu , Capatina Cristina , Poiana Catalina

IntroductionPituitary apoplexy is a rare entity characterized by abrupt hemorrhage and/or ischaemia of the constituents of sella turcica. It usually occurs in a previously unsuspected pituitary tumor. It may have an acute or subclinical presentation and it may represent a neuroendocrinological emergency.AimThis study aims to analyze predisposing or precipitating factors, clinical status, imaging and hormonal ...